| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |